Your Health, We Care
Gilteritinib is indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FMS-like tyrosine kinase 3 (FLT3) mutation as detected by an FDA-approved test.
FDA,2022.01
How does gilteritinib work?In patients with acute myeloid leukemia (AML), the bone marrow produces a large number of abnormal white blood cells. These cells cannot perform normal i···【more】
Article source：Lucius LaosRelease date：2026-04-14Recommended：42
What is Gilteritinib?Gilteritinib (generic name: gilteritinib) works in a fundamentally different way from traditional chemotherapy. Traditional chemotherapy fights cancer by killi···【more】
Article source：Lucius LaosRelease date：2026-04-10Recommended：40
Indications and EfficacyThe main component of Gilteritinib Fumarate Tablets is gilteritinib fumarate, which is an anti-tumor medication.This medication should be used under the gui···【more】
Article source：Lucius LaosRelease date：2026-03-11Recommended：55
Gilteritinib is suitable for Leukemia.【more】
Article source：Lucius LaosRelease date：2026-01-06Recommended：30
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
